Compare NNNN & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | AZTA |
|---|---|---|
| Founded | 2021 | 1978 |
| Country | Germany | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | N/A | 1996 |
| Metric | NNNN | AZTA |
|---|---|---|
| Price | $16.79 | $23.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $40.60 |
| AVG Volume (30 Days) | 21.2K | ★ 990.0K |
| Earning Date | 04-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.52 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $593,821,000.00 |
| Revenue This Year | N/A | $6.99 |
| Revenue Next Year | N/A | $5.98 |
| P/E Ratio | $446.57 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.50 | $15.93 |
| 52 Week High | $55.65 | $41.73 |
| Indicator | NNNN | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 33.36 | 57.13 |
| Support Level | $14.66 | $21.77 |
| Resistance Level | $31.12 | $24.36 |
| Average True Range (ATR) | 3.11 | 0.92 |
| MACD | -0.97 | 0.08 |
| Stochastic Oscillator | 9.95 | 47.10 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.